For a more complete understanding of the present invention, including its features and advantages, reference is now made to the detailed description of the invention taken in conjunction with the accompanying drawing in which:
While the making and using of various embodiments of the present invention are discussed in detail below, it should be appreciated that the present invention provides many applicable inventive concepts that may be embodied in a wide variety of specific contexts. The specific embodiments discussed herein are merely illustrative of specific ways to make and use the invention and do not delimit the scope of the invention.
For many years dehydroepiandrosterone (DHEA) has been studied and found to have positive effects on patients. DHEA is the most common steroid hormone in the body. It is produced in the adrenal glands and within the skin. DHEA is metabolized from pregnenolone, the body's “master hormone,” which itself is metabolized from cholesterol. DHEA production has also been found to decrease as humans get older and seems to peak when a person is about 25 years old. DHEA replacement therapy normally consists of patients taking oral supplements but the therapy is still evolving.
An embodiment of the present invention utilizes a topical DHEA cream consisting about 5% DHEA and is applied directly on the skin. Application directly on the skin helps replenish the DHEA normally produced within the skin in patients over 25. Consequently, direct skin application has been found to improve the overall health of a patient. In addition, positive effects have been found if the cream is applied to thin vascular skin such as between the inner arm and the side of the arm or flank.
Another embodiment utilizes the topical DHEA cream with a body moisturizing lotion. In this embodiment, Twist25® topical DHEA cream and St. Ives® with vitamin E lotion is used, however, other similar products can also be used. This embodiment contemplates mixing an equal part of the lotion and the topical DHEA cream together and applying the topical DHEA/lotion mixture to the body of a patient.
DHEA/lotion can also be applied to the nipples and clitoris of a female patient and the head of a male's penis. This application has been shown to improve libido and sexual response of the patients. One reason that this type of application helps is because the combined DHEA/lotion mixture has been shown to have a strong affinity for the Sex Hormone Binding Globulin (SHBG).
Additionally, the topical DHEA cream can also be used with a body and massage lotion that contains sulfate, such as Lasting Touch™ Deep Tissue Therapy and Massage lotion, for additional benefits. In this embodiment the topical DHEA cream is also combined with an equal portion of the sulfate lotion (s-lotion). Then, the combined DHEA/s-lotion mixture is applied to the scalp 108, knees 110 and the waist 112 of the patient 100. These types of applications have a strong affinity for serum albumin and positively effect cognition, depression and mobility. In addition, the applications affect global self-rated health for men and especially women. Moreover, the applications lower blood pressure and improve cardiovascular health in men. Further, the applications are antagonistic to cortisol and thus decrease abdominal fat. The applications also improve the skin and joints and increase hair growth.
Although this invention has been described with reference to an illustrative embodiment, this description is not intended to limit the scope of the invention. Various modifications and combinations of the illustrative embodiments as well as other embodiments of the invention will be apparent to persons skilled in the art upon reference to the description. It is therefore intended that the claims accomplish any such modifications or embodiments.
This application claims the benefit of U.S. Provisional Application Ser. No. 61/075,602 filed on Jun. 25, 2008, the contents of which are hereby incorporated by reference herein.
Number | Date | Country | |
---|---|---|---|
61075602 | Jun 2008 | US |